Tim Bancroft

1.4k total citations
55 papers, 955 citations indexed

About

Tim Bancroft is a scholar working on Epidemiology, Economics and Econometrics and Surgery. According to data from OpenAlex, Tim Bancroft has authored 55 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 8 papers in Economics and Econometrics and 6 papers in Surgery. Recurrent topics in Tim Bancroft's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Vaccine Coverage and Hesitancy (5 papers) and Virology and Viral Diseases (4 papers). Tim Bancroft is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Vaccine Coverage and Hesitancy (5 papers) and Virology and Viral Diseases (4 papers). Tim Bancroft collaborates with scholars based in United States, Canada and United Kingdom. Tim Bancroft's co-authors include Şerban R. Iorga, Warren Greth, Ami Buikema, Jonathan P. Kelly, Craig J. Newschaffer, Jaclyn Marshall, Anjali Jain, Ancilla W. Fernandes, Alan B. Ettinger and Edward Faught and has published in prestigious journals such as Science, JAMA and Journal of Clinical Oncology.

In The Last Decade

Tim Bancroft

50 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tim Bancroft United States	18	182	179	146	125	110	55	955
Rose‐Marie Javier France	18	304 1.7×	93 0.5×	210 1.4×	125 1.0×	20 0.2×	72	1.3k
Liraz Olmer Israel	23	118 0.6×	161 0.9×	40 0.3×	48 0.4×	250 2.3×	64	1.7k
Gaspare Cucinella Italy	27	110 0.6×	123 0.7×	243 1.7×	75 0.6×	35 0.3×	109	2.0k
Rebecca Holmes United States	20	362 2.0×	205 1.1×	64 0.4×	167 1.3×	36 0.3×	41	1.7k
Atsuko Murashima Japan	19	97 0.5×	246 1.4×	482 3.3×	80 0.6×	114 1.0×	117	1.5k
Sen Hee Tay Singapore	19	110 0.6×	134 0.7×	397 2.7×	70 0.6×	65 0.6×	53	1.4k
Paras Karmacharya United States	22	156 0.9×	100 0.6×	454 3.1×	61 0.5×	231 2.1×	81	1.3k
Argiris Asderakis United Kingdom	13	161 0.9×	226 1.3×	75 0.5×	59 0.5×	48 0.4×	36	1.3k
Fay J. Hosking United Kingdom	21	97 0.5×	416 2.3×	48 0.3×	320 2.6×	48 0.4×	28	1.9k
Anna Radziszewska United Kingdom	14	68 0.4×	208 1.2×	161 1.1×	84 0.7×	37 0.3×	33	1.4k

Countries citing papers authored by Tim Bancroft

Since Specialization

Citations

This map shows the geographic impact of Tim Bancroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Bancroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Bancroft more than expected).

Fields of papers citing papers by Tim Bancroft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Bancroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Bancroft. The network helps show where Tim Bancroft may publish in the future.

Co-authorship network of co-authors of Tim Bancroft

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Bancroft. A scholar is included among the top collaborators of Tim Bancroft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Bancroft. Tim Bancroft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vu, Michelle, et al.. (2025). Adverse consequences of systemic corticosteroids use among a broad population of US adults with asthma: a real-world analysis. Journal of Medical Economics. 28(1). 413–424.

Cleveland, Noa Krugliak, Sabyasachi Ghosh, Benjamin Chastek, et al.. (2024). Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY. BMC Gastroenterology. 24(1). 314–314. 2 indexed citations

Chastek, Benjamin, et al.. (2024). Comparative analysis of real‐world adherence and persistence patterns with vibegron, mirabegron, and anticholinergics in patients with overactive bladder: A retrospective claims study. Neurourology and Urodynamics. 43(7). 1504–1513. 6 indexed citations

McGovern, Ian, Benjamin Chastek, Tim Bancroft, et al.. (2024). Relative vaccine effectiveness of MF59-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the 2017–2020 influenza seasons. International Journal of Infectious Diseases. 146. 107160–107160. 1 indexed citations

Chastek, Benjamin, et al.. (2024). Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis. Advances in Therapy. 41(5). 2086–2097. 1 indexed citations

Cleveland, Noa Krugliak, Sabyasachi Ghosh, Benjamin Chastek, et al.. (2023). Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY. Inflammatory Bowel Diseases. 30(10). 1776–1787. 9 indexed citations

Murphy, Louise B., Amy Nguyen, Cori Blauer‐Peterson, et al.. (2023). Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting. Journal of Comparative Effectiveness Research. 13(2). e230142–e230142.

Norman, Gregory J., Misti L. Paudel, Christopher G. Parkin, Tim Bancroft, & Peter Lynch. (2022). Association Between Real-Time Continuous Glucose Monitor Use and Diabetes-Related Medical Costs for Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics. 24(7). 520–524. 20 indexed citations

Fisher, Lloyd D., Matthew M. Loiacono, Nick Payne, et al.. (2022). A novel household‐based patient outreach pilot program to boost late‐season influenza vaccination rates during the COVID‐19 pandemic. Influenza and Other Respiratory Viruses. 16(6). 1141–1150. 3 indexed citations

10.

Wong, Robert J., Janet Lee, Tim Bancroft, et al.. (2020). Hepatitis C Screening Rates and Care Cascade in a Large US Insured Population, 2010–2016: Gaps to Elimination. Population Health Management. 24(2). 198–206. 6 indexed citations

11.

Ghaswalla, Parinaz, Lindsay G.S. Bengtson, Gary S. Marshall, et al.. (2020). Meningococcal vaccination in patients with newly diagnosed asplenia in the United States. Vaccine. 39(2). 272–281. 16 indexed citations

12.

Taylor, Douglas C.A., et al.. (2018). Health Care Resource Use and Costs Pre- and Post-Treatment Initiation With Linaclotide: Retrospective Analyses of a U.S. Insured Population.. PubMed. 27(2). 33–40. 2 indexed citations

13.

Armstrong, April W., Yang Zhao, Vivian Herrera, et al.. (2017). Drivers of Healthcare Costs Among the Costliest Patients With Psoriasis Over Three Years in a United States Health Plan.. PubMed. 16(7). 651–658. 4 indexed citations

14.

Maiese, Eric M., et al.. (2016). Quality of life of HIV-infected patients who switch antiretroviral medication due to side effects or other reasons. Current Medical Research and Opinion. 32(12). 2039–2046. 14 indexed citations

15.

Shiozawa, Aki, Puja Khanna, Valery Walker, et al.. (2015). Health-related quality of life and treatment satisfaction in patients with gout: results from a cross-sectional study in a managed care setting. Patient Preference and Adherence. 9. 971–971. 25 indexed citations

16.

Altan, Aylin, Aki Shiozawa, Tim Bancroft, & Jasvinder A. Singh. (2015). A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan Database. JCR Journal of Clinical Rheumatology. 21(8). 411–418. 9 indexed citations

17.

Burton, Tanya, Elisabeth Le Nestour, Tim Bancroft, & Maureen P. Neary. (2012). Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases. Pituitary. 16(3). 354–362. 18 indexed citations

18.

Furst, Daniel E., Ancilla W. Fernandes, Şerban R. Iorga, Warren Greth, & Tim Bancroft. (2012). Annual Medical Costs and Healthcare Resource Use in Patients with Systemic Sclerosis in an Insured Population. The Journal of Rheumatology. 39(12). 2303–2309. 27 indexed citations

19.

Furst, Daniel E., Anthony A. Amato, Şerban R. Iorga, Tim Bancroft, & Ancilla W. Fernandes. (2012). Medical costs and health‐care resource use in patients with inflammatory myopathies in an insured population. Muscle & Nerve. 46(4). 496–505. 17 indexed citations

20.

Swanson-Wagner, Ruth A., Rhonda DeCook, Yi Jia, et al.. (2009). Paternal Dominance of Trans-eQTL Influences Gene Expression Patterns in Maize Hybrids. Science. 326(5956). 1118–1120. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact